# Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC

> **NCT06251115** · NA · RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 9 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** QY-1-T

## Key facts

- **NCT ID:** NCT06251115
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-10-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06251115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06251115, "Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06251115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*